Clorox director Christopher J. Williams acquires stock units

Q: What deferred stock units did CLX director Christopher J. Williams acquire?

Christopher J. Williams acquired 339.4642 deferred stock units on September 30, 2026, in lieu of quarterly director's fees, and 276.2573 units on August 28, 2026, through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.

Q: When will Christopher J. Williams's CLX deferred stock units be settled?

The units will be settled 100% in Clorox stock in connection with Christopher J. Williams's retirement or other termination of service as a director.

A director's deferred units will be settled 100% in Clorox stock in connection with retirement or other termination of service.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Clorox (CLX) director Christopher J. Williams acquired 339.4642 deferred stock units on September 30, 2026, in lieu of quarterly director's fees, and 276.2573 units on August 28, 2026, through dividend reinvestment under the Independent Directors' Deferred Compensation Plan. His reported direct common-stock holding was 849 shares as of September 30, 2026. The deferred units will be settled 100% in Clorox stock in connection with his retirement or other termination of service as a director.

Insider Trade Summary

Grant/Award: 615.7215 shares

Grant/Award 3 txns

Insider WILLIAMS CHRISTOPHER J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units ^{F1, F4, F3}	339.4642	$0.00	$0.00
holding	Common Stock	--	--	--
Grant/Award	Deferred Stock Units ^{F1, F2, F3}	276.2573	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 23,275.4528 contracts (Direct); Common Stock — 849 shares (Direct)

Footnotes (4)

F1. 1-for-1
F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

Key Figures

Deferred stock units acquired: 339.4642 deferred stock units Deferred stock units acquired: 276.2573 deferred stock units Direct common-stock holding: 849 shares

3 metrics

Deferred stock units acquired 339.4642 deferred stock units In lieu of quarterly director's fees on September 30, 2026

Deferred stock units acquired 276.2573 deferred stock units Through dividend reinvestment on August 28, 2026

Direct common-stock holding 849 shares As of September 30, 2026

Key Terms

Deferred Stock Units, Independent Directors' Deferred Compensation Plan, dividend reinvestment, settled 100% in Clorox stock

4 terms

Deferred Stock Units financial

"Deferred Stock Units acquired through dividend reinvestment"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Independent Directors' Deferred Compensation Plan financial

"pursuant to the Independent Directors' Deferred Compensation Plan"

A deferred compensation plan for independent directors lets outside board members postpone receiving part of their fees or stock awards until a later date, often when they retire or leave the board. Think of it as choosing to put pay into a company-run savings plan that grows and pays out later; it matters to investors because it affects director incentives, future cash or share obligations, and how aligned independent directors are with long-term company performance.

dividend reinvestment financial

"acquired through dividend reinvestment during the fiscal year"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

settled 100% in Clorox stock financial

"will be settled 100% in Clorox stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What deferred stock units did CLX director Christopher J. Williams acquire?

Christopher J. Williams acquired 339.4642 deferred stock units on September 30, 2026, in lieu of quarterly director's fees, and 276.2573 units on August 28, 2026, through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.

When will Christopher J. Williams's CLX deferred stock units be settled?

The units will be settled 100% in Clorox stock in connection with Christopher J. Williams's retirement or other termination of service as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/02/2026 - 04:16 PM Accepted by SEC EDGAR 10/02/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILLIAMS CHRISTOPHER J

(Last)

(First)

(Middle)

1221 BROADWAY

(Street)

OAKLAND

CALIFORNIA

94612-1888

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								849	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	08/28/2026		A⁽²⁾	V	276.2573		⁽³⁾	⁽³⁾	Common Stock	276.2573	$0.0000	22,935.9886	D
Deferred Stock Units	⁽¹⁾	09/30/2026		A⁽⁴⁾		339.4642		⁽³⁾	⁽³⁾	Common Stock	339.4642	$0.0000	23,275.4528	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR